Cargando…
Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter
Most therapeutic monoclonal antibodies in biopharmaceutical processes are produced in Chinese hamster ovary (CHO) cells. Technological advances have rendered the selection procedure for higher producers a robust protocol. However, information on molecular mechanisms that impart the property of hyper...
Autores principales: | Dahodwala, Hussain, Kaushik, Prashant, Tejwani, Vijay, Kuo, Chih-Chung, Menard, Patrice, Henry, Michael, Voldborg, Bjorn G., Lewis, Nathan E., Meleady, Paula, Sharfstein, Susan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311070/ https://www.ncbi.nlm.nih.gov/pubmed/32577618 http://dx.doi.org/10.1016/j.crbiot.2019.09.001 |
Ejemplares similares
-
Inferring secretory and metabolic pathway activity from omic data with secCellFie
por: Masson, Helen O., et al.
Publicado: (2023) -
Strategies for adaptation of mAb-producing CHO cells to serum-free medium
por: Costa, A Rita, et al.
Publicado: (2011) -
Novel strategy for a high-yielding mAb-producing CHO strain (overexpression of non-coding RNA enhanced proliferation and improved mAb yield)
por: Tabuchi, Hisahiro
Publicado: (2013) -
How to assess chemically defined media and feeds from 9 suppliers on CHO cells producing mAb
por: Polès-Lahille, Aurore, et al.
Publicado: (2013) -
Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells
por: Nematpour, Fatemeh, et al.
Publicado: (2017)